Coronavirus disease 2019 (COVID-19) vaccines proved a strong clinical efficacy against
symptomatic or moderate/severe COVID-19 and are considered the most promising …

COVID-19 vaccines substantially changed the course of the pandemic, saving millions of
lives on a global scale [1]. According to the latest evidence, 64.85% of the world's population …

Abstract Background Coronavirus disease 2019 (COVID-19) vaccines have been proven to
decrease the severity of acute-phase infection; however, little is known about their effect on …

This brief report examined the frequency and characteristics of a significant blood-pressure
(BP) increase after Pfizer-BioNTech BNT162b2 vaccination among healthcare workers who …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread across the
world, killing more than 4 million individuals globally, with 240 million individuals being …

Background Thirteen COVID-19 vaccines are granted emergency approval. It is crucial to
monitor their adverse events post vaccination. The present study focuses on cardiovascular …

Due to the patient high throughput in our vaccination center, we do not have prevaccination
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …

Given the urgent need to control the spread of the novel COVID-19 virus, 13 vaccines have
been approved for emergency use before completing all 3 phases of the clinical trials …

Among the various comorbidities potentially worsening the clinical outcome in patients
hospitalized for the acute respiratory syndrome coronavirus-2 (SARS-CoV-2), hypertension …

Objectives To evaluate the cardiovascular safety of COVID-19 vaccines in the real world.
Methods Studies reported on any COVID-19 vaccine-related cardiovascular events in the …